Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 1 | 2022 | 49 | 0.820 |
Why?
|
| Polymers | 2 | 2010 | 117 | 0.600 |
Why?
|
| Electrolytes | 3 | 2004 | 25 | 0.570 |
Why?
|
| Ions | 3 | 2004 | 61 | 0.530 |
Why?
|
| Water | 3 | 2004 | 283 | 0.470 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2009 | 2 | 0.350 |
Why?
|
| X-Rays | 1 | 2009 | 17 | 0.350 |
Why?
|
| Lipid Bilayers | 2 | 2007 | 66 | 0.340 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 51 | 0.340 |
Why?
|
| Thermodynamics | 2 | 2007 | 207 | 0.340 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 164 | 0.310 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.300 |
Why?
|
| Salts | 1 | 2007 | 15 | 0.300 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 178 | 0.300 |
Why?
|
| Models, Chemical | 2 | 2004 | 201 | 0.290 |
Why?
|
| Algorithms | 1 | 2009 | 435 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2007 | 210 | 0.270 |
Why?
|
| Spectrum Analysis, Raman | 3 | 2018 | 84 | 0.230 |
Why?
|
| Phenylalanine | 1 | 2022 | 20 | 0.220 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 18 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 416 | 0.180 |
Why?
|
| Antioxidants | 1 | 2022 | 386 | 0.170 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 57 | 0.170 |
Why?
|
| Serotonin | 1 | 2018 | 114 | 0.160 |
Why?
|
| Microscopy | 1 | 2018 | 32 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 81 | 0.160 |
Why?
|
| Surface Properties | 2 | 2010 | 121 | 0.160 |
Why?
|
| Dopamine | 1 | 2018 | 232 | 0.150 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 19 | 0.150 |
Why?
|
| Cytokines | 1 | 2020 | 569 | 0.150 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 52 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 70 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 282 | 0.130 |
Why?
|
| Colloids | 2 | 2005 | 17 | 0.130 |
Why?
|
| Poisson Distribution | 2 | 2003 | 39 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1149 | 0.100 |
Why?
|
| Adsorption | 1 | 2010 | 67 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2009 | 15 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 55 | 0.080 |
Why?
|
| Linear Models | 1 | 2009 | 253 | 0.080 |
Why?
|
| Humans | 6 | 2022 | 34853 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 347 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1426 | 0.070 |
Why?
|
| Latex | 1 | 2005 | 1 | 0.070 |
Why?
|
| Chemistry | 1 | 2003 | 17 | 0.060 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 53 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 342 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2003 | 171 | 0.050 |
Why?
|
| Proteins | 1 | 2005 | 352 | 0.050 |
Why?
|
| Survival Rate | 1 | 2020 | 310 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 707 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 964 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 114 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 107 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2016 | 100 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 210 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 649 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2128 | 0.020 |
Why?
|
| Female | 2 | 2017 | 19873 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 6448 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 5668 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 55 | 0.020 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 1984 | 2 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 14307 | 0.010 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1984 | 1 | 0.000 |
Why?
|
| Giant Cell Tumors | 1 | 1984 | 1 | 0.000 |
Why?
|
| Mesenchymoma | 1 | 1984 | 1 | 0.000 |
Why?
|
| Neurofibroma | 1 | 1984 | 1 | 0.000 |
Why?
|
| Fibroma | 1 | 1984 | 4 | 0.000 |
Why?
|
| Papilloma | 1 | 1984 | 15 | 0.000 |
Why?
|
| Teratoma | 1 | 1984 | 8 | 0.000 |
Why?
|
| Polyps | 1 | 1984 | 9 | 0.000 |
Why?
|
| Adenoma | 1 | 1984 | 89 | 0.000 |
Why?
|